C-Reactive-Protein-Associated Increase in Myocardial Infarct Size After Ischemia/Reperfusion
- 1 December 2002
- journal article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Journal of Pharmacology and Experimental Therapeutics
- Vol. 303 (3), 1007-1013
- https://doi.org/10.1124/jpet.102.040600
Abstract
C-Reactive protein (CRP), a marker for acute inflammation, is associated with increased risk of cardiovascular events. The mechanism underlying this association is uncertain. An acute inflammatory response was induced in rabbits by subcutaneous injection of croton oil (CO) 1 to 3 days before 30 min of regional myocardial ischemia/180 min of reperfusion. CO treatment increased plasma CRP from below the limit of detection to 2.5 ± 0.5 mg/dl and was associated with an increase in infarct size expressed as percentage of risk region [32 ± 6% vehicle controls (n = 7) to 47 ± 9% CO-treated rabbits (n = 7;P < 0.05]. After 10 min of ischemia and 180 min reperfusion, no infarct was found in controls; however, an infarct of 7 ± 1% was found in CO-treated rabbits (P < 0.05; CRP, 2.3 ± 0.4 mg/dl). The CRP-related increase in infarct size was not observed in croton oil-treated, C6-deficient rabbits (n = 5/group), indicating the involvement of complement. In these rabbits, infarct size was 22 ± 2% (P < 0.05) despite having plasma CRP of 4.3 ± 0.4 mg/dl. The CRP-associated increase in infarct size was ameliorated by pretreatment with heparin (n = 7; infarct size 33 ± 3%; CRP, 2.3 ± 0.3 mg/dl;P < 0.05) or N-acetylheparin (n = 7; infarct size 23 ± 4%; CRP, 3.1 ± 0.5 mg/dl; P < 0.05). These observations may explain why increased serum CRP is associated with an augmented risk for cardiovascular events.Keywords
This publication has 34 references indexed in Scilit:
- Function of C-reactive proteinAnnals of Medicine, 2000
- C-Reactive Protein and Complement Are Important Mediators of Tissue Damage in Acute Myocardial InfarctionThe Journal of Experimental Medicine, 1999
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- C-reactive protein and complement in myocardial infarction and postinfarction heart failureEuropean Heart Journal, 1997
- Activated inflammatory cells are associated with plaque rupture in carotid artery stenosisSurgery, 1997
- Selective inhibition of the alternative complement pathway by sCR1[desLHR-a]protects the rabbit isolated heart from human complement-mediated damageImmunopharmacology, 1996
- Cardioprotective effects of heparin or N-acetylheparin in an in vivo model of myocardial ischaemic and reperfusion injuryCardiovascular Research, 1995
- Effects of heparin and N-acetyl heparin on ischemia/reperfusion-induced alterations in myocardial function in the rabbit isolated heart.Circulation Research, 1994
- IMMUNOLOGIC CROSS-REACTIONS AMONG MAMMALIAN ACUTE PHASE PROTEINSThe Journal of Experimental Medicine, 1960
- THE OCCURRENCE IN THE RABBIT OF AN ACUTE PHASE PROTEIN ANALOGOUS TO HUMAN C-REACTIVE PROTEINThe Journal of Experimental Medicine, 1951